Gaviscon Tablet and Insulin aspart, recombinant Subcutaneous
Determining the interaction of Gaviscon Tablet and Insulin aspart, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: aluminum hydroxide / magnesium trisilicate
Brand name: Gaviscon Tablet, Drysol, Hypercare, Xerac AC
Synonyms: Aluminum Hydroxide and Magnesium Trisilicate
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Gaviscon Tablet-Insulin degludec
- Gaviscon Tablet-Insulin Degludec (U-100) Prefilled Pens
- Gaviscon Tablet-Insulin Degludec (U-100) Vials
- Gaviscon Tablet-Insulin Degludec (U-200) Prefilled Pens
- Gaviscon Tablet-Insulin degludec and liraglutide
- Gaviscon Tablet-Insulin degludec and liraglutide Subcutaneous
- Insulin aspart, recombinant Subcutaneous-Gazyva
- Insulin aspart, recombinant Subcutaneous-Gefitinib
- Insulin aspart, recombinant Subcutaneous-Gefitinib Oral
- Insulin aspart, recombinant Subcutaneous-Gel-One
- Insulin aspart, recombinant Subcutaneous-Gel-One injection
- Insulin aspart, recombinant Subcutaneous-Gelato Topical Anesthetic